Last updated: September 10, 2019
Sponsor: Tel Aviv Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Tourette's Syndrome
Tic Disorders
Autism
Treatment
N/AClinical Study ID
NCT04087616
TelAvivSMO
Ages 8-17 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Clinical diagnosis of Tourette Syndrome or Chronic Tic Disorder.
Yale Global Tic Severity Scale tic severity score ≥14.
Exclusion
Exclusion Criteria:
Change in psychotropic medication regimen during the past 6 weeks.
Current diagnosis of substance abuse/dependence.
Lifetime diagnosis of pervasive developmental disorder, mania or psychosis.
Previous sessions of CBIT.
Study Design
Total Participants: 40
Study Start date:
July 01, 2019
Estimated Completion Date:
May 01, 2020
Study Description
Connect with a study center
1Interdisciplinary Center (IDC)
Herzliya,
IsraelActive - Recruiting
Tel Aviv Sourasky Medical Center
Tel Aviv,
IsraelActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.